Khor T H, Chia K B, Chua E J, Sethi V K, Tan B C, Tan T M
Int J Radiat Oncol Biol Phys. 1985 Jul;11(7):1313-6. doi: 10.1016/0360-3016(85)90246-9.
The results of 322 patients with uterine cervix carcinoma treated by radiotherapy at the Singapore General Hospital in the 3-year period from 1973 to 75 are presented. Two hundred seventy-nine patients were treated with a combination of intracavitary radium, using Fletcher-Suit applicators and cobalt teletherapy; the remaining 43 patients received only cobalt teletherapy. One hundred thirty-four patients (41.6%) presented with FIGO Stage III disease. Only 46 patients (14.3%) presented with Stage I disease, showing that patients tended to present late in the disease course. Five-year actuarial (uncorrected) survival rates of 86.7% for Stage I, 65.0% for Stage II, 41.4% for Stage III and 4.9% for Stage IV were obtained with corresponding 10 year rates of 79.6%, 60.2%, 35.2% and 0%. The overall 5 and 10 year survival rates were 54.0% and 48.2%, respectively. The survival rates "flattened off" at about 7-8 years, reflecting late deaths after the fifth anniversary of treatment. Non-severe complications consisted mainly of chronic proctitis (41.3%) and vaginal stenosis (20.8%). Major complications were intestinal stricture (1.2%) and fistula formation (1.6%).
本文呈现了1973年至1975年期间在新加坡总医院接受放射治疗的322例子宫颈癌患者的治疗结果。279例患者采用弗莱彻 - 休特施源器进行腔内镭疗与钴远距离治疗相结合的方式;其余43例患者仅接受钴远距离治疗。134例患者(41.6%)为国际妇产科联盟(FIGO)III期疾病。仅有46例患者(14.3%)为I期疾病,这表明患者往往在病程后期才前来就诊。I期患者的5年精算(未校正)生存率为86.7%,II期为65.0%,III期为41.4%,IV期为4.9%,相应的10年生存率分别为79.6%、60.2%、35.2%和0%。总体5年和10年生存率分别为54.0%和48.2%。生存率在大约7 - 8年时“趋于平稳”,反映出治疗后第五年之后的晚期死亡情况。非严重并发症主要包括慢性直肠炎(41.3%)和阴道狭窄(20.8%)。主要并发症为肠道狭窄(1.2%)和瘘管形成(1.6%)。